Ozcan, O. U. Et Al. 2015. Impact of Metabolic Syndrome on Development of Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention Among Nondiabetic Patients. CLINICAL CARDIOLOGY , vol.38, no.3 , 150-156.

Ozcan, O. U., Er, H. A., GÜLEÇ, H. S., Ustun, E. E., GEREDE ULUDAĞ, D. M., Goksuluk, H., ... TULUNAY KAYA, C.(2015). Impact of Metabolic Syndrome on Development of Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention Among Nondiabetic Patients. CLINICAL CARDIOLOGY , vol.38, no.3, 150-156.

Ozcan, Ozgur Et Al. "Impact of Metabolic Syndrome on Development of Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention Among Nondiabetic Patients," CLINICAL CARDIOLOGY , vol.38, no.3, 150-156, 2015

Ozcan, Ozgur U. Et Al. "Impact of Metabolic Syndrome on Development of Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention Among Nondiabetic Patients." CLINICAL CARDIOLOGY , vol.38, no.3, pp.150-156, 2015

Ozcan, O. U. Et Al. (2015) . "Impact of Metabolic Syndrome on Development of Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention Among Nondiabetic Patients." CLINICAL CARDIOLOGY , vol.38, no.3, pp.150-156.

@article{article, author={Ozgur Ulas Ozcan Et Al. }, title={Impact of Metabolic Syndrome on Development of Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention Among Nondiabetic Patients}, journal={CLINICAL CARDIOLOGY}, year=2015, pages={150-156} }